Boron tribromide → (3-(4-Hydroxyphenylsulfonamido)phenyl)boronic acid
Reaction equation
C[O:2][C:3]1[CH:8]=[CH:7][C:6]([S:9]([NH:12][C:13]2[CH:18]=[CH:17][CH:16]=[C:15]([B:19]3[O:23]C(C)(C)C(C)(C)[O:20]3)[CH:14]=2)(=[O:11])=[O:10])=[CH:5][CH:4]=1.B(Br)(Br)Br>ClCCl>[OH:2][C:3]1[CH:8]=[CH:7][C:6]([S:9]([NH:12][C:13]2[CH:14]=[C:15]([B:19]([OH:23])[OH:20])[CH:16]=[CH:17][CH:18]=2)(=[O:11])=[O:10])=[CH:5][CH:4]=1Participants
4
Procedure
4-Methoxy-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzenesulfonamide (168 mg, 0.43 mmol) was dissolved in dichloromethane (4 ml). A solution of boron tribromide (1M in dichloromethane, 4.32 mL, 4.32 mmol) was added dropwise and the reaction was stirred at room temperature overnight. The mixture was diluted with dichloromethane and washed with a solution of 4% sodium bicarbonate, water, brine and dried over sodium sulphate, filtered and evaporated under reduced pressure. The product was purified by reverse phase using SP1® Purification System to give 30 mg (23% yield) of the title compound. Purity 100%.
Workup
- washwashed with a solution of 4% sodium bicarbonate, water, brine
- dry with materialdried over sodium sulphate
- filtrationfiltered
- customevaporated under reduced pressure
- customThe product was purified by reverse phase
- custom® Purification System
Sources & evidence
- ORD record
- ord-0b1089e3130c4f0199df94d557058a90
- Source dataset
- uspto-grants-2016_07
- Patent number
- US09388189B2
Reaction notes
Loading…